SCHEMBL6989330

SCHEMBL6989330

NCCCN1CCN(c2ccccn2)CC1

nearest known ligand 0.79

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.69
POLB P06746 1/20 0.69
DRD2 P14416 8/20 0.65
DRD3 P35462 8/20 0.65
HTR1A P08908 6/20 0.65
HTR2A P28223 5/20 0.65
HTR7 P34969 5/20 0.65
DRD4 P21917 3/20 0.65
DRD1 P21728 4/20 0.61
ADRA2C P18825 3/20 0.61
DRD5 P21918 3/20 0.61
HRH1 P35367 3/20 0.61
HTR2C P28335 1/20 0.60
CYP2D6 P10635 1/20 0.59
SIGMAR1 Q99720 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3674703 0.95 KCNH2 (0.72) KCNH2POLBDRD2DRD3HTR1A
Hydrochloric Acid SCHEMBL3812906 0.94 KCNH2 (0.70) KCNH2POLBDRD2DRD3HTR1A
SCHEMBL1307947 0.90 KCNH2 (0.64) KCNH2POLBDRD2DRD3HTR1A
Hydrochloric Acid SCHEMBL2516709 0.89 KCNH2 (0.62) KCNH2POLBDRD2DRD3HTR1A
SCHEMBL4519313 0.89 KCNH2 (0.85) KCNH2POLBDRD2DRD3HTR1A
SCHEMBL26107525 0.89 KCNH2 (0.85) KCNH2POLBDRD2DRD3HTR1A
SCHEMBL26108725 0.89 KCNH2 (0.85) KCNH2POLBDRD2DRD3HTR1A
Hydrochloric Acid SCHEMBL26108256 0.87 KCNH2 (0.83) KCNH2POLBDRD2DRD3HTR1A
SCHEMBL13711971 0.87 KCNH2 (0.71) KCNH2POLBDRD2DRD3HTR1A
SCHEMBL3683389 0.86 KCNH2 (0.71) KCNH2POLBDRD2DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927184-B1 3-SUBSTITUTED PYRIDO 4',3':4,5]THIENO 2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE ABBOTT GMBH & CO KG (DE) 2003-10-22 EP disclosed
US-6387912-B1 STROKE THERAPY BASF AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
CN-1332168-A 3-substituted pyrido-[4',3':4,5] thieno-[2,3-d] pyrimidine derivatives, their prep. and use BASF AG (DE) 2002-01-23 CN disclosed
EP-1140096-A1 UTILIZATION OF PYRIMIDINE DERIVATIVES FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA BASF AKTIENGESELLSCHAFT (DE) 2001-10-10 EP disclosed
US-6222034-B1 AS SEROTININ RECEPTOR ANTAGONISTS; FOR THERAPY OF DEPRESSION, CENTRAL NERVOUS SYSTEM DISORDERS BASF AKTIENGESELLSCHAFT (DE) 2001-04-24 US disclosed
WO-2000041695-A1 UTILIZATION OF PYRIMIDINE DERIVATIVES FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA BASF AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed
CN-1230962-A 3-substituted pyrido [4',3':4,5] thieno [2, 3-d ] pyrimidine derivatives, their preparation and use BASF AG (DE) 1999-10-06 CN disclosed
EP-0927184-A1 3-SUBSTITUTED PYRIDO 4',3':4,5]THIENO 2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1999-07-07 EP disclosed
WO-1998011110-A1 3-SUBSTITUTED PYRIDO[4',3':4,5]THIENO[2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1998-03-19 WO disclosed
EP-0082402-B1 SUCCINIMIDE DERIVATES AND PROCESS FOR PREPARATION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-04-02 EP disclosed
US-4543355-A Substituted succinimides, compositions and method of use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-09-24 US disclosed
US-4507303-A Succinimide derivatives, compositions and method of use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-03-26 US disclosed
EP-0082402-A2 Succinimide derivates and process for preparation thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-06-29 EP disclosed